InvestorsHub Logo

norisknorewards

07/07/22 2:30 PM

#493176 RE: StonkMaster #493175

had the same question, thanks

GoodGuyBill

07/07/22 4:18 PM

#493246 RE: StonkMaster #493175

Here's the exact wording from the email (Bold/red emphasis added for emphasis):

Dear William,

We are pleased to send you our most recent release regarding further progress made at our Sawston, UK facility. Northwest Biotherapeutics has announced that an application for a manufacturing license for commercial manufacturing of cellular therapies (after the therapies receive regulatory approval) has been submitted to the regulatory authorities. This manufacturing license is separate from any application for approval of DCVax-L itself.


Best,


Dave Innes
VP, Investor Relations
Northwest Bio?therapeutics, Inc.